Company Filing History:
Years Active: 1987-1988
Title: The Innovative Contributions of Robert Broersma, Jr.
Introduction
Robert Broersma, Jr., located in Noblesville, IN, is a distinguished inventor known for his impactful contributions to pharmacology through his innovations in antihypertensive agents. With a total of two patents, he has made significant strides in developing novel compounds aimed at improving health outcomes.
Latest Patents
Robert's latest patents include the following groundbreaking inventions:
1. **Novel Allylic Amines** - This invention pertains to novel β-methylenethiophenethanamines, which are mechanism-based inhibitors of dopamine beta-hydroxylase, offering potential as antihypertensive agents.
2. **β-Methylene Furanethanamines and Use as Anti-Hypertensive Agents** - This patent describes novel β-methylenefuranethanamines, which serve as mechanism-based inhibitors of dopamine beta-hydroxylase, also valuable in the treatment of hypertension.
Career Highlights
Robert Broersma, Jr. is associated with Merrell Dow Pharmaceuticals, a significant player in the pharmaceutical industry. His contributions in drug invention are noteworthy, particularly focusing on treatments for high blood pressure.
Collaborations
In his professional journey, Robert has collaborated with notable coworkers such as Thomas M. Bargar and James R. McCarthy, enriching his research endeavors and contributions to the field. Their collective expertise has undoubtedly enhanced the innovative potential of their projects.
Conclusion
Robert Broersma, Jr.'s work exemplifies the spirit of innovation within the pharmaceutical industry. His patents are a testament to his dedication to improving healthcare through novel inventions focused on managing hypertension effectively. As he continues to push the boundaries of pharmacology, his contributions remain vital in the ongoing quest for better health solutions.